The Infection Surveillance Solutions Market is estimated to be valued at US$ 683.8 Mn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Infection Surveillance Solutions refers to software programs and services that help healthcare facilities to efficiently detect, track, and manage infections. They provide electronic and automated ways to collect, analyze and report data related to various hospital acquired infections. This streamlines the process of surveillance and helps hospitals to implement effective infection control prevention programs.

Market key trends:
Rising number of surgical site infections (SSIs) across the world is a major factor driving the demand for infection surveillance solutions. As per the CDC, around 158,000 to 357,000 SSIs are reported annually in the US. These infections increase the length of hospital stay by 7-11 days on average and also doubles the medical costs. Infection surveillance solutions allow real-time monitoring of SSIs by tracking patient outcomes across populations. This helps hospitals to identify high risk factors and implement targeted measures to reduce infections. Growing awareness about benefits of automated surveillance systems in preventing secondary infections is also fueling the adoption of these solutions globally. Various government initiatives to promote quality care are further expected to boost the infection surveillance solutions market during the forecast period.

Porter’s Analysis

Threat of new entrants: Low capital requirements prevent new players from entering the infection surveillance solutions market. However, established brands have advantages associated with scale and experience that create barriers.
Bargaining power of buyers: Large hospitals and healthcare systems possess significant buyer power to negotiate on price and demand additional services. However, need for infection control solutions keeps buyer power in check.
Bargaining power of suppliers: A few major players dominate the supply of key infection surveillance technologies like software and medical devices, allowing them to influence prices. Suppliers rely on branding and proprietary technologies for differentiation.
Threat of new substitutes: No viable alternatives currently exist that can offer the comprehensive functionality of infection surveillance solutions. However, certain point solutions may substitute components.
Competitive rivalry: Major providers compete through differentiated offerings, geographies and expanding services. Price competition is moderate due to need for customized systems.

SWOT Analysis

Strengths: Increasing investment towards digitalization of healthcare infrastructure enables growth. Solutions offer real-time monitoring and enhanced decision making to curb infections.
Weaknesses: High costs associated with deployment and maintenance of solutions limits adoption. Lack of skilled resources hampers complex solution integration.
Opportunities: Growing geriatric population prone to infections creates demand. Integration of AI and predictive analytics opens new avenues.
Threats: Data security and privacy risks associated with digitization slows market acceptance. Reimbursement uncertainties and budgetary constraints affect sales.

Key Takeaways

The global Infection Surveillance Solutions Market is expected to witness high growth, exhibiting CAGR of 14% over the forecast period, due to increasing investment by governments and healthcare organizations towards curbing infections and AMR. North America dominates the market currently due to presence of majority key players and advanced healthcare infrastructure in the region. The Asia Pacific region is expected to grow at the fastest rate over the coming years due increasing healthcare expenditure and focus on digitalization of hospitals in countries like India and China.

Regional analysis Regional analysis North America is expected to dominate the global infection surveillance solutions market during the forecast period. This is attributed to presence of major market players in the region along with growing need to curb infections in healthcare facilities. Asia Pacific infection surveillance solutions market is projected to witness highest growth over the forecast period, registering a CAGR of around 15%. Factors such as increasing healthcare investments coupled with focus on hospital infrastructure upgradation particularly in India and China are driving the regional market growth.

Key players operating in the Infection Surveillance Solutions market are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc.,